scholarly journals An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
B. S. M. S. Siriwardena ◽  
K. L. T. D. Jayawardena ◽  
N. H. Senarath ◽  
W. M. Tilakaratne

Background. The behavior and prognosis of oral squamous cell carcinoma (OSCC) is presumably different in patients with oral submucous fibrosis (OSF). The objective of this study was to assess the effects of demographic features, habits, and histopathological features in the transformation of OSF to OSCC. Methods. Data were extracted from the archives and histopathological evaluation and presence of nodal metastasis were recorded. Results. OSF was detected in 130 (48%) out of 273 OSCC patients. The mean age of presentation among OSF-positive patients was 57.7 years, while patients diagnosed only with OSCC had a comparatively higher age, 59.5 years. In the below 50 years of age group, presence of OSF with OSCC was less (40%). In the OSF-positive group, male to female ratio was 3.2:1. The common primary sites were buccal mucosa and tongue in both groups. Betel quid chewing was present in more than 95% of the sample. Betel chewing, smoking, and alcohol consumption were present in 26.15% of OSF-positive patients. Degree of fibrosis was neither associated with the level of histological differentiation of the tumor (p= 0.195) nor associated with the malignant transformation (p =0.373). Lymph node metastasis was not seen in 76.63% and 68.54% of the patients with and without OSF, respectively. Conclusions. High degree of prevalence of OSF was observed among the OSCC patients. There were also a male predilection and younger age at presentation in these patients. However, a significant association was not observed in the degree of fibrosis with malignant transformation or the level of histopathological differentiation of the tumor. Lymph node metastasis also failed to express a significant relationship with the presence of OSF.

2018 ◽  
Vol 38 (11) ◽  
pp. 6157-6162 ◽  
Author(s):  
SATOMI ARIMOTO ◽  
TAKUMI HASEGAWA ◽  
DAISUKE TAKEDA ◽  
IZUMI SAITO ◽  
RIKA AMANO ◽  
...  

2019 ◽  
Vol 16 (4) ◽  
pp. 363-373
Author(s):  
Binbin Yu ◽  
Wei Cao ◽  
Chenping Zhang ◽  
Ronghui Xia ◽  
Jinlin Liu ◽  
...  

2020 ◽  
Vol 9 (2) ◽  
pp. 295 ◽  
Author(s):  
Ting-An Lin ◽  
Tai-Sheng Wu ◽  
Yue-Ju Li ◽  
Cheng-Ning Yang ◽  
Monica Maria Illescas Ralda ◽  
...  

Background: Metastasis is a severe problem in patients with oral squamous cell carcinoma (OSCC), which is the fifth most common cancer worldwide. Leukemia inhibitory factor (LIF) has been studied in different cancers, while the role of LIF in OSCC remains unclear. Methods: LIF expression was detected in 100 OSCC samples by immunohistochemistry. Effects of LIF on cell motility were evaluated in OSCC cell lines. High-throughput microarray analysis was also conducted. The correlation between LIF and the downstream effector was analyzed by real-time quantitative reverse transcription PCR. Results: Patients with OSCC who had lymph node metastasis or advanced cancer stages showed high LIF expression. OSCC patients with higher LIF expression, advanced stage, large tumor size, or lymph node metastasis had significantly shorter overall survival. LIF regulated cancer cell motilities through outside-in signaling. The inhibin beta A subunit (INHBA) gene was identified as a crucial downstream effector of LIF-promoted OSCC progression and restored migration and invasion abilities in LIF knockdown transfectants. Conclusion: LIF enhances regional lymphatic spread, thus leading to an advanced cancer stage. Regulation of LIF downstream molecules such as INHBA inhibits the invasion or migration ability of cancer cells. Thus, LIF can be a potential target in preventing cancer metastasis and spread.


Sign in / Sign up

Export Citation Format

Share Document